Pentao Liu left the Wellcome Sanger Institute in January 2018 to become Professor of Biomedical Sciences in the Li Ka Shing Faculty of Medicine and Stem Cell Centre at the University of Hong Kong. This page is no longer being updated and is maintained as historical record of the group's research at the Sanger Institute.
Sanger Institute, Genome Research Limited
Our Research and Approach
We use various approaches including genetics, genomics and cell biology to study gene functions in normal development and disease such as cancer. We are particularly interested in stem cell self-renewal, differentiation, and lineage choice.
We used various approaches including genetics, genomics and cell biology to study gene functions in normal development and disease such as cancer. We were particularly interested in stem cell self-renewal, differentiation, and lineage choice.
Throughout life, the genome within cells of the human body is exposed to DNA damage and suffers mistakes in replication. These corrosive influences result in progressive, subtle divergence of the DNA sequence in each cell from that originally constituted in the fertilised egg. The Cancer Genome Project uses high-throughput genome sequencing to identify these somatically acquired mutations with the aim of characterising cancer genes, mutational processes and patterns of clonal evolution in human tumours.
The Bradley laboratory is a multi-disciplinary environment with a number of parallel research themes. One of our core disciplines is the development and use of genetic technologies which we primarily apply to the mouse genome, although we also embrace studies in other mammalian genomes.
The Microbial Pathogenesis team, under the leadership of Professor Gordon Dougan, focused on the genetic analysis of the interactions between bacteria and their hosts to shed light on how humans and other animals respond to infection.